Clinical trial
Immune Biomarkers Related to Bone Pathology in Patients With Type 1 Gaucher Disease
NCT04055831 is registered in ClinicalTrials.gov with Lysosomal and Rare Disorders Research and Treatment Center, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Biomarkers Related to Bone Pathology in Patients With Type 1 Gaucher Disease
- Lead sponsor
- Lysosomal and Rare Disorders Research and Treatment Center, Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 15, 2019
- Completion date
- May 15, 2020
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gaucher disease type 1